Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose propofol before awake extubation in children with upper respiratory tract infection
PACTR202412599188741Phase 0Not yet recruiting
- Sponsor
- Hedi Chaker Hospital
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 0, randomised trial in upper respiratory infection (URI) comparing Propofol group with Placebo group (2 arms). Primary endpoint: Incidence of respiratory adverse events. Planned start Dec 2024; status: not yet recruiting.
02
Drugs
propofol
03
Conditions
upper respiratory infection (URI)
Beyond the preview
Go deeper on PACTR202412599188741.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202412599188741.